EyePoint (EYPT) Non-Current Assets (2011 - 2026)
EyePoint (EYPT) reported Non-Current Assets of $38.7 million for Q1 2026, up 8.8% on a YoY basis from $35.6 million in Q1 2025, and up 9.54% sequentially from $35.3 million in Q4 2025.
EyePoint (EYPT) Non-Current Assets (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 16 years of Non-Current Assets data on file, last reported at $38.7 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets rose 8.8% year-over-year to $38.7 million; the trailing twelve-month figure through Mar 2026 stood at $145.5 million (up 9.9% YoY), and the FY2025 full-year result was $35.3 million, up 0.52% from the prior year.
- Non-Current Assets advanced to $38.7 million in Q1 2026, from $35.3 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $38.7 million in Q1 2026 to a low of $7.5 million in Q4 2022.
- A 5-year average of $24.4 million and a median of $28.4 million in 2022 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets slumped 70.55% in 2022 and jumped 243.42% in 2024, its largest moves.
- Tracing EYPT's Non-Current Assets over 5 years: stood at $7.5 million in 2022, then soared by 37.57% to $10.4 million in 2023, then jumped by 238.59% to $35.2 million in 2024, then climbed by 0.52% to $35.3 million in 2025, then rose by 9.54% to $38.7 million in 2026.
- Business Quant data shows EYPT's Non-Current Assets at $38.7 million in Q1 2026, $35.3 million in Q4 2025, and $35.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | 38.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.71 Mn |
| Dec 31, 2025 | 35.34 Mn |
| Sep 30, 2025 | 35.59 Mn |
| Jun 30, 2025 | 35.90 Mn |
| Mar 31, 2025 | 35.58 Mn |
| Dec 31, 2024 | 35.16 Mn |
| Sep 30, 2024 | 32.37 Mn |
| Jun 30, 2024 | 29.32 Mn |
| Mar 31, 2024 | 11.54 Mn |
| Dec 31, 2023 | 10.38 Mn |
| Sep 30, 2023 | 9.88 Mn |
| Jun 30, 2023 | 8.54 Mn |
| Mar 31, 2023 | 8.54 Mn |
| Dec 31, 2022 | 7.55 Mn |
| Sep 30, 2022 | 28.39 Mn |
| Jun 30, 2022 | 27.57 Mn |
| Mar 31, 2022 | 24.93 Mn |
| Dec 31, 2021 | 25.63 Mn |
| Sep 30, 2021 | 26.48 Mn |
| Jun 30, 2021 | 27.00 Mn |